Myology research highlights

RSS feed

Brain imaging in myotonic dystrophy type 1

  Here, the authors systematically review brain imaging studies in myotonic dystrophy type 1 (DM1) from 81 studies. They extracted clinical characteristics, primary outcomes, clinical-genetic correlations, and information on potential risk of bias. Results were summarized and pooled prevalence of imaging abnormalities was calculated, where possible. They conclude that DM1 brains show widespread white and … [Read more]

Clinical and mutational spectrum of Japanese patients with MORC2

  The microrchidia family CW-type zinc finger 2 gene (MORC2) was newly identified as a causative gene of Charcot-Marie-Tooth disease (CMT) type 2Z in 2016. Here, the author describe the clinical and mutational spectrum of patients with CMT harboring MORC2 mutations in Japan, the largest report of patients harboring MORC2 variants. Samples from 781 unrelated … [Read more]

Newborn screening to diagnose SMA before symptom onset

  This study aimed to demonstrate the feasibility of presymptomatic diagnosis spinal muscular atrophy (SMA) through newborn screening (NBS). A screening trial was performed to assess all newborns who underwent routine newborn metabolic screening at the National Taiwan University Hospital newborn screening center between November 2014 and September 2016. A real-time polymerase chain reaction (RT-PCR) … [Read more]

Long-term treatment with leuprorelin for SBMA

This natural history-controlled study evaluated the prognosis and progression of spinal and bulbar muscular atrophy (SBMA), a rare X-linked motor neuron disorder caused by trinucleotide repeat expansion in the AR (androgen receptor) gene, after long-term androgen suppression with leuprorelin acetate treatment. A total of 36 patients with SBMA were treated with leuprorelin acetate for up … [Read more]

Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy

GNE myopathy is a rare, autosomal recessive, inborn error of sialic acid metabolism, caused by mutations in GNE, the gene encoding UDP-N-acetyl-glucosamine-2-epimerase/N-acetylmannosamine kinase. The disease manifests as an adult-onset myopathy characterized by progressive skeletal muscle weakness and atrophy. There is no medical therapy available for this debilitating disease. Hyposialylation of muscle glycoproteins likely contributes to … [Read more]

Novel clinical and pathological features in cystinosis distal myopathy

  Nephropathic cystinosis is an autosomal recessive lysosomal disease in which cystine cannot exit the lysosome to complete its degradation in the cytoplasm, thus accumulating in tissues. Some patients develop a distal myopathy involving mainly hand muscles. Myopathology descriptions from only 5 patients are available in the literature. Here, the authors present a comprehensive clinical, … [Read more]

A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome

  Multinucleate cellular syncytial formation is a hallmark of skeletal muscle differentiation. Myomaker, encoded by Mymk (Tmem8c), is a well-conserved plasma membrane protein required for myoblast fusion to form multinucleated myotubes in mouse, chick, and zebrafish. This multinational study reports that autosomal recessive mutations in MYMK (OMIM 615345) cause Carey-Fineman-Ziter syndrome in humans (CFZS; OMIM … [Read more]

Tricyclo-DNA antisense oligonucleotide treatment: A promising systemic alternative for treating SMA

Spinal muscular atrophy (SMA) is a recessive disease caused by mutations in the SMN1 gene, which encodes the protein survival motor neuron (SMN), whose absence dramatically affects the survival of motor neurons. In humans, the severity of the disease is lessened by the presence of a gene copy, SMN2. SMN2 differs from SMN1 by a … [Read more]

Gene therapy: Microdystrophin restores muscle strength in DMD

Researchers from Genethon and the Institute of Myology, AFM-Téléthon laboratories, Inserm (UMR 1089, Nantes) and the University of London (Royal Holloway) demonstrated the efficacy of an innovative gene therapy in the treatment of Duchenne muscular dystrophy. Indeed, after injecting microdystrophin (a “shortened” version of the dystrophin gene) via a drug vector, the researchers managed to … [Read more]

Wide spectrum of clinical severity in affected female carriers of MTM1 mutations

X-linked myotubular myopathy (XLMTM), a severe congenital myopathy, is caused by mutations in the MTM1 gene located on the X chromosome. A majority of affected males die in the early postnatal period, whereas female carriers are believed to be usually asymptomatic. Nevertheless, several affected females have been reported. To assess the phenotypic and pathological spectra … [Read more]